MCC Update 10-29-13
Update is an official newsletter of the Masonic Cancer Center for faculty, members, staff, colleagues, and friends. All submissions for the next issue must be sent to Sandi Sherman, email@example.com, by noon on Friday for publication the following Tuesday.
October 29, 2013
Note new location!
PLEASE NOTE: Seminars will NOT be simulcast to MCRB. Shuttles to CCRB may be boarded in front of Variety Club Heart Clinic on E. River Parkway. See website for details on pick-up time.
Tuesday, October 29, 2013, 12-1 p.m., 1-125 Cancer and Cardiovascular Research Building
The dynamics of androgen receptor action in breast cancer cells
Wayne Tilley, Ph.D., Director, Dame Roma Mitchell Cancer Research Laboratory, University of Adelaide and Hanson Institute
Host: Scott Dehm, Ph.D.
A peek at next week’s seminar:
No seminar on November 5.
Visit the calendar for a schedule of seminars.
Sandeep Kataria named Masonic Cancer Center director of Research Informatics
The following message is from Douglas Yee, M.D., director of the Masonic Cancer Center:
We are pleased to announce the promotion of Sandeep Kataria to the role of Masonic Cancer Center Director of Research Informatics. His promotion stems from the recent NCI competitive review of the Cancer Center Support Grant, which endorsed the establishment of OMIS as an independent shared resource core, noting that of the Clinical Shared Resource Group “OMIS is "most promising" and that "the services and expertise provided by this Shared Resource are critical to the clinical research mission of the MCC." He will continue to report to the Sarah Cooley, MD, MS, who serves as both the Medical Director of the OMIS and the Associate Director for the Cancer Experimental Therapeutics Initiative. Sandeep’s expanded responsibilities for the Oncology Medical Informatics and Services Shared Resource now include oversight of the staff and services that support our unique domain specific clinical trials, registry and translational data management needs. He will represent the Masonic Cancer Center on local and national platforms. Sandeep will work closely with the AHC-AIS to ensure that the MCC OMIS group facilitates institutional enterprise solutions, whenever possible, whenever possible, to meet researcher needs and complies with standards and regulations governing the management of health care and research data. He will lead the development of the MCC OMIS strategic planning and multi-year roadmap.
Congratulations to Mark Osborn, Ph.D., Transplant Biology and Therapy Program, along with Elizabeth Braunlin, M.D., Ph.D., on being the inaugural recipient, of the John and Nancy Lindahl Children’s Heart Research Fund Innovators Award from the CTSI Office of Discovery and Translation 2013 Novel Methods Pilot Funding program.
Kudos to Michelle Gleason, Ph.D., Ross lab, who received a $500 American Society of Hematology (ASH) Abstract Achievement Award for her abstract submission “A novel CD16xCD33 bispecific killer cell engager (BiKE) mediates a double hit for natural killer (NK) cells to target CD33all disease stages.” The award is meant to defray the expenses for travel to the ASH meeting in December.
The following clinical trials conducted by Masonic Cancer Center members were recently opened:
Immune-Monitoring Of Patients With Non Muscle Invasive Bladder Cancer Being Treated With Intra Vesical BCG (Bacille Calmette–Guérin)
PI: Jha, Gautam
A Randomized, Double-Blind, Phase III Study of the Efficacy and Safety of Gemcitabine in Combination With TH-302 Compared With Gemcitabine in Combination With Placebo in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
PI: Greeno, Edward
For more information on clinical trials contact Marva Bohen, R.N., B.S.N. (firstname.lastname@example.org, 612-624-2620).
Genetic Mechanisms of Cancer Program
Friday, November 1, 2013, 12-1 p.m., 450 MCRB
Discussion of program review in CCSG summary statement and future plans
Anja Bielinsky, Ph.D., co-leader, Genetic Mechanisms of Cancer Program
Visit the calendar for a schedule of meetings.
November 6, 2013: Mouse Necropsy Workshop
9-11:30 a.m., Room 495, Animal Science/Veterinary Medicine
This workshop will be led by CPSR board certified veterinary pathologists, Drs. Johnson, Kovi and O’Sullivan. It is designed for individuals who are doing in vivo studies in mice with endpoints necessitating necropsy and collection of tissues, and is appropriate for principal investigators, postdocs, graduate students and technicians. Participants will learn how to necropsy mice and identify and collect tissues of interest. Issues related to optimum handling and fixation of tissues will be emphasized. The registration fee is $100. Places are limited and reserved on a first come-first served basis. To reserve a place please email email@example.com.
Contact Josh Parker at 612 625 9770, firstname.lastname@example.org with questions.
November 8, 2013: Donald Gleason Conference on Urologic and Prostate Cancers
The Commons Hotel
To advance our collective knowledge related to early diagnosis, proper staging, and effective treatment of prostate and kidney cancer, the University of Minnesota has assembled a top-notch faculty to share updates and best practices that include:
- Role of MYC and its Neighbors in Cancer: There's More Than Meets the Eye
- A Prostate Cancer Nanotherapeutic Targeting CK2
- Co-morbidity Effect on TRAIL-based Immunotherapy for RCC
- C11 Acetate - Better Diagnosis And Treatment Decisions For Prostate Cancer
- Advances in Kidney Surgery: Robots, Spared Nephrons, and Single Ports
Keynote speakers are: Patrick Kupelian, M.D., UCLA; Joel Nelson, M.D., University of Pittsburgh Medical Center Cancer Center; Dipen J. Parekh, M.D., University of Miami Miller School of Medicine; Arkadiusz Dudek, M.D., Ph.D., University of Illinois Cancer Center
For full conference details and to register, go to www.cme.umn.edu/urologiccancers,
November 9, 2013: Morality and Care Practices at the End of Life
Registration is open for a Bioethics Professional Development Seminar sponsored by the Center for Bioethics. The Nov 9 half-day seminar “Morality and Care Practices at the End-of-Life” offers professionals who work with dying patients and their families the opportunity to advance their understanding of moral issues in decision-making and care at the end of life. Distinguished faculty members from the University of Minnesota's Center for Bioethics will present their latest research, share their insights, and engage seminar participants in discussion of these complex issues affecting their professional practice. Students are also encouraged to attend. For registration and further information see Bioethics Professional Development Seminar, call 612-624-9440 or email the Center for Bioethics
November 18 & 19, 2013: Distinguished Visiting Scholar Series on Health Disparities
Moon Chen, Jr., Ph.D., M.P.H., Professor, Division of Hematology and Oncology, Department of Internal Medicine, Associate Director, Population Research and Cancer Disparities, UC Davis Comprehensive Cancer Center
Dr. Chen leads the largest project ever undertaken to curb cancer in Asian Americans. Known as the Asian American Network for Cancer Awareness, Research and Treatment (AANCART), the national program is based at UC Davis Cancer Center and funded by the National Cancer Institute as part of an effort to reduce ethnic disparities in cancer. Dr. Chen specializes in developing linguistically specific, culturally tailored and population-based health interventions.
November 18: Community Dialogue
3:30 p.m., Lao Center, 503 N Irving Ave, Minneapolis
November 19: Reducing cancer health disparities among Asian Americans
11:45 a.m.: lunch for first 60 people, 12:05; 1:05 p.m.: program, 1-450 Moos Tower
November 20, 2013: The Power of Partnerships: Poster Session & Awards Dinner
4-7 p.m., Amherst H. Wilder Foundation, 451 Lexington Pkwy N, St. Paul, Minn. Poster session at 4:00; networking and dinner at 5:00; program at 5:30
The Program in Health Disparities Research (PHDR), Clinical and Translational Science Institute (CTSI), and Center for Health Equity (CHE) will hold their 2013 Poster Session and Awards Banquet where research presentations from the PHDR Pilot Grants in Health Disparities Research program, CTSI Collaborative Pilot Grant awardees, and research poster presentations from CHE/CTSI Scholars will be given. This poster session will also feature pilot grant awardees and the work of local community organizations dedicated to reducing health disparities.
This event is free of charge. Please RVSP here by November 15, 2013.
December 12, 2013: Sixth Annual David A. Rothenberger Lecture
4 p.m., Mayo Auditorium
Will physicians lead us through health care challenges?
Bill George, former chair and chief executive of Medtronic; professor of management practice at Harvard Business School; board member: Mayo Clinic, Exxon Mobil and Goldman Sachs; former chair of the board of Allina Health System and Abbott Northwestern Hospital
January 22, 2014: Save the date: Writing Winning Grant Proposals
8:30 a.m.-4 p.m., McNamara Alumni Center
Learn how to write successful health research grants at "Write Winning Grant Proposals," a day-long seminar that's back by popular demand. National speaker and grant-writing expert John D. Robertson, Ph.D., will comprehensively address practical and conceptual aspects important to the proposal-writing process.
Hosted by the Clinical and Translational Science Institute, Center for Health Equity and Minnesota Center for Cancer Collaborations.
Contact Megan Hoffman at 612-626-4120 or email@example.com for more information
Visit the Education and Training Opportunities web page for more conference and special lecture listings.
November 7, 2013: Pancreatic Cancer Concert - 2nd Annual Event
6-11 p.m., Bayview Event Center, Excelsior, Minn.
John Cafferty and Michael "Tunes" Antunes/Beaver Brown Band; the music from Eddie & and Cruisers Movie 30th anniversary; special guest Kevin Chalfant Journey Experience; opening act Big City. This all-ages event originated and inspired by Gary Wellner and his family will benefit the Masonic Cancer Center at the University of Minnesota.
General admission: $35; advance tickets: $25. For tickets and information contact Mike Woodley, 612-386-0082
May 17, 2014: Save the Date: Cancer Survivorship Series
Click here to be added to the Cancer Survivor Program mailing list to receive registration information for this conference when it is available closer to the date.
Visit the Community Events and Outreach page for more information.
Sub-Saharan African Collaborative HIV and Cancer Consortia (U54)
National Cancer Institute
Application Receipt Date(s): January 17, 2014
Funding: $750,000/yr for 5 years
Research on Malignancies in the Context of HIV/AIDS (R01)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: Standard limits apply.
Administrative Supplements to NIH Awards for Validation Studies of Analytical Methods for Natural Products
National Cancer Institute
Application Receipt Date(s): January 31, 2014; June 30, 2014, October 31, 2014; January 31 2015; June 30 2015; October 31, 2015
Funding: Application budgets are limited to no more than 25% of the Council-approved direct costs for the current budget year of the project or $100,000 (total direct costs) whichever is less
Visit the Funding Opportunities Web page to see listings previously published in Update. A list of organizations that provide funding for cancer research is also provided there.